J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, H. H.
Right arrow Articles by Rinke, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, H. H.
Right arrow Articles by Rinke, L. M.

Journal of Animal Science, Vol 69, Issue 11 4538-4544, Copyright © 1991 by American Society of Animal Science

JOURNAL ARTICLE

The pharmacokinetics and residues of clenbuterol in veal calves

H. H. Meyer and L. M. Rinke
Institut fur Physiologie der Suddeutschen Versuchs und Forschungsanstalt fur Milchwirtschaft, Technische Universitat Munchen, FRG.

Seven female Brown Swiss calves were used to study the pharmacokinetics of clenbuterol after an effective anabolic dosage of 5 micrograms/kg of BW was given twice daily for 3 wk. Analyses of clenbuterol concentrations in different tissues was done by enzyme immunoassay (EIA). Tissue samples were taken from three calves on the last day of administration and from two more after 3.5 or 14 d of clenbuterol withdrawal. The rate of clenbuterol elimination was dependent on time and tissue. Clenbuterol concentrations in the lung dropped from a mean of 76 ng/g to a level of less than .08 ng/g after 14 d, whereas in the liver the clenbuterol concentrations decreased from 46 ng/g to .6 ng/g within 14 d of withdrawal. Highest levels were always found in the eye: 118 ng/g, 57.5 ng/g, and 15.1 ng/g after 0, 3.5, and 14 d of withdrawal, respectively. These data reveal that different compartments contribute to the elimination of clenbuterol; therefore, concentrations in urine do not follow first order kinetics. An initial rapid decline in the concentration of clenbuterol in urine with a half-life of 10 h is followed by a slower elimination with a half-life of about 2.5 d. Treatments using the anabolic dose of 5 micrograms/kg of BW require longer withdrawal times than the therapeutic dose (.8 micrograms/kg BW).


This article has been cited by other articles:


Home page
 J ANIM SCIHome page
D. J. Smith, K. M. Ehrenfried, J. D. Dalidowicz, and M. P. Turberg
Binding of ractopamine HCl to ocular tissues of cattle and turkeys in vivo and to melanin in vitro
J Anim Sci, November 1, 2002; 80(11): 2931 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
N. W. Shappell, L. O. Billey, and V. J. Feil
Effects of clenbuterol on body stores of polychlorinated dibenzofurans (PCDF) and dibenzo-p-dioxins (PCDD) in rats
J Anim Sci, September 1, 2002; 80(9): 2461 - 2475.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
M. N. Sillence, K. J. Munn, and R. G. Campbell
Manipulation of growth in pigs through treatment of the neonate with clenbuterol and somatotropin
J Anim Sci, July 1, 2002; 80(7): 1852 - 1862.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Zalko, E. Perdu-Durand, L. Debrauwer, M.-P. Bec-Ferte, and J. Tulliez
Comparative Metabolism of Clenbuterol by Rat and Bovine Liver Microsomes and Slices
Drug Metab. Dispos., January 1, 1998; 26(1): 28 - 35.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society of Animal Science.